Matthew Matasar, Division Chief, Blood Disorders at Rutgers Cancer Institute, shared on LinkedIn:
I had the pleasure of working with Elizabeth Brem and MedscapeCME on a program focusing on bispecific antibodies in marginal zone lymphoma.
Definitely an area of needed study and an opportunity for the field!”
Other articles about lymphoma on OncoDaily.